dc.contributor.author | McLaughlin, Gavin | |
dc.contributor.author | Baumann, Michael H. | |
dc.contributor.author | Kavanagh, Pierce V. | |
dc.contributor.author | Morris, Noreen | |
dc.contributor.author | Power, John D. | |
dc.contributor.author | Dowling, Geraldine | |
dc.contributor.author | Twamley, Brendan | |
dc.contributor.author | O'Brien, John | |
dc.contributor.author | Hessman, Gary | |
dc.contributor.author | Westphal, Wolker | |
dc.contributor.author | Walther, Donna | |
dc.contributor.author | Brandt, Simon D. | |
dc.date.accessioned | 2019-04-23T08:22:47Z | |
dc.date.available | 2019-04-23T08:22:47Z | |
dc.date.copyright | 2018-04 | |
dc.date.issued | 2018-09 | |
dc.identifier.citation | Gavin McLaughlin et al (2018). Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers. Drug Testing and Analysis. Sep;10(9):1404-1416. doi: 10.1002/dta.2396. | en_US |
dc.identifier.issn | 1942-7603 | |
dc.identifier.uri | https://research.thea.ie/handle/20.500.12065/2640 | |
dc.description.abstract | The availability of new psychoactive substances on the recreational drug
market continues to create challenges for scientists in the forensic, clinical
and toxicology fields. Phenmetrazine (3-methyl-2-phenylmorpholine) and an
array of its analogs form a class of psychostimulants that are well
documented in the patent and scientific literature. The present study reports
on two phenmetrazine analogs that have been encountered on the NPS drug
market following the introduction of 3-fluorophenmetrazine (3-FPM), namely
4-methylphenmetrazine (4-MPM) and 3-methylphenmetrazine (3-MPM). This
study describes the syntheses, analytical characterization and
pharmacological evaluation of the positional isomers of MPM. Analytical
characterizations employed various chromatographic, spectroscopic and
mass spectrometric platforms. Pharmacological studies were conducted in
order to assess whether MPM isomers might display stimulant-like effects
similar to the parent compound phenmetrazine. The isomers were tested for
their ability to inhibit uptake or stimulate release of tritiated substrates at
dopamine, norepinephrine and serotonin transporters using in vitro transporter
assays in rat brain synaptosomes. The analytical characterization of three
vendor samples revealed the presence of 4-MPM in two of the samples and
3-MPM in the third sample, which agreed with the product label. The
pharmacological findings suggest that 2-MPM and 3-MPM will exhibit
stimulant properties similar to the parent compound phenmetrazine, whereas
4-MPM may display entactogen properties more similar to MDMA. The
combination of test purchases, analytical characterization, targeted organic
synthesis and pharmacological evaluation of NPS and their isomers is an
effective approach for the provision of data on these substances as they
emerge in the marketplace. | en_US |
dc.format | PDF | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Drug Testing and Analysis | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | * |
dc.subject | Psychotropic drugs | en_US |
dc.subject | Designer drugs | en_US |
dc.subject | Psychostimulants | en_US |
dc.title | Synthesis, analytical characterization and monoamine transporter activity of the new psychoactive substance 4- methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers | en_US |
dc.type | Article | en_US |
dc.description.peerreview | yes | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-2496-8396 | |
dc.rights.access | Open Access | en_US |
dc.subject.department | Faculty of Science and Health | en_US |